• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Viscogliosi Brothers Completes Acquisition of U.S. Spine Business from Stryker, Creating VB Spine, LLC

    4/1/25 4:26:42 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care
    Get the next $SYK alert in real time by email

    VB Spine is a Strategic Partner to Stryker with Access to Mako Spine and Copilot

    Marc, John and Anthony Viscogliosi Lead VB Spine as Co-Chief Executive Officers

    NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- Viscogliosi Brothers, LLC, a family-owned investment office specializing in the neuro-musculoskeletal space, today announced the successful completion of its previously announced acquisition of the U.S. spine business from Stryker (NYSE:SYK). The business will operate as a standalone company under the name VB Spine, LLC ("VB Spine").

    VB Spine is advancing toward the completion of its acquisition of Stryker's international spine businesses, pending satisfaction of legal and regulatory requirements, including all required employee consultations. VB Spine is focused on successfully growing and evolving the spine business and expanding its reach to serve surgeons and patients globally.

    VB Spine is dedicated to bringing physicians and patients comprehensive and advanced technology solutions that are clinically proven to deliver improved patient outcomes through surgeon-driven innovation. With a focus on operational excellence and a patient-first approach, VB Spine aims to address critical needs in spine surgery and deliver meaningful improvements in patients' lives. VB Spine's value proposition to all stakeholders lies in its comprehensive product portfolio, strong distribution network and deep industry expertise, enabling it to provide specialized solutions that empower surgeons and enhance patient care. VB Spine is led by Marc, John and Anthony Viscogliosi, co-founders of Viscogliosi Brothers, LLC.

    "We are honored to work alongside such a talented team and are confident that, with its strong commitment to innovation, surgeon collaboration and commercial execution, VB Spine is uniquely positioned to improve patient outcomes and drive transformation in spine surgery," said Marc, John and Anthony Viscogliosi.

    "Viscogliosi Brothers has traditionally been known as a leader in spine technology innovations. With the launch of VB Spine, we are building on our innovation legacy by investing in the people and organization that will drive the next phase of transformation in the spine industry. This transaction represents a major milestone in our dedication to operate a portfolio of innovative and enabling technologies that can improve patient outcomes globally. We look forward to welcoming the rest of the Stryker Spine family as we move forward in our growth strategy through completing the additional phases of the acquisition in markets outside the U.S.," continued Messrs. Viscogliosi.

    VB Spine has access to Stryker's Mako Spine and Copilot. This strategic partnership creates a strong foundation for VB Spine's continued growth, providing surgeons greater precision and improving patient outcomes.

    In connection with the transaction, Barings, LLC and Texas Capital Bank are serving as financial partners to Viscogliosi Brothers. Viscogliosi Brothers and Viscogliosi Brothers Watermark Holdings, LLC are equity investors in VB Spine.

    Viscogliosi Brothers, LLC was advised in this transaction by McDermott Will & Emery as legal counsel, Piper Sandler as financial advisor, FTI Consulting as carve-out advisors and Deloitte IT and Deloitte Tax as additional carve-out advisory.

    About VB Spine

    VB Spine, LLC is the largest privately held spine company and among the largest family-owned medical technology companies in the world. Our globally recognized identity as innovators and stewards of the spine industry reflects our commitment to patient outcomes first. With a comprehensive product portfolio and a large and growing global distribution network, VB Spine delivers specialized solutions that address critical needs in spine surgery and enhance patient outcomes. VB Spine is a strategic partner to Stryker with access to Mako Spine and Copilot. Focused on people, partnerships and operational excellence, VB Spine ensures healthcare professionals have access to the tools and resources needed to provide the highest standard of care. VB Spine is owned and led by the Viscogliosi Brothers. For more information on VB Spine, please visit www.vbspineco.com.

    About Viscogliosi Brothers

    Viscogliosi Brothers, LLC is a family-owned New York City-based family office dedicated to driving growth and innovation in the neuro-musculoskeletal industry. Established in 1999, the firm focuses on identifying and building groundbreaking innovations in healthcare, aiming to address unmet clinical needs, enhance patient outcomes, and drive cost efficiency in the healthcare system. Since its inception 26 years ago, Viscogliosi Brothers has founded, financed, operated and grown 43 businesses with operations and distribution across more than 80 countries. These businesses have positively impacted millions of patients with cutting-edge innovations in healthcare. The firm has led the transformation of the spine industry through its multiple businesses specifically including: Spine Solutions, Spine Next, Paradigm Spine, Simplify Medical, Centinel Spine, Companion Spine, Spine BioPharma and Woven Orthopedic Technologies, among others. For more information, visit www.vbllc.com.

    About Viscogliosi Brothers Watermark

    Viscogliosi Brothers Watermark LLC is a New York City-based holding company specializing in investing in innovation within the MedTech sector. Founded in 2022, VBW is committed to creating alternative wealth for its shareholders while enhancing humanity's well-being. With a portfolio-driven investment mandate and strategic expertise, VBW supports its invested entities through financing and manufacturing capabilities. For more information, visit www.vbwholdings.com.

    About Barings

    Barings is a $421+ billion* global asset management firm that partners with institutional, insurance, and intermediary clients, and supports leading businesses with flexible financing solutions. The firm, a subsidiary of MassMutual, seeks to deliver excess returns by leveraging its global scale and capabilities across public and private markets in fixed income, real assets and capital solutions. For more information, visit www.barings.com

    *Assets under management as of December 31, 2024

    About Texas Capital

    Texas Capital Bancshares, Inc. (NASDAQ®: TCBI), a member of the Russell 2000® Index and the S&P MidCap 400®, is the parent company of Texas Capital Bank ("TCB"). Texas Capital is the collective brand name for TCB and its separate, non-bank affiliates and wholly-owned subsidiaries. Texas Capital is a full-service financial services firm that delivers customized solutions to businesses, entrepreneurs and individual customers. Founded in 1998, the institution is headquartered in Dallas with offices in Austin, Houston, San Antonio and Fort Worth, and has built a network of clients across the country. With the ability to service clients through their entire lifecycles, Texas Capital has established commercial banking, consumer banking, investment banking and wealth management capabilities. All services are subject to applicable laws, regulations, and service terms. Deposit and lending products and services are offered by TCB. For deposit products, member FDIC. For more information, please visit www.texascapital.com.

    About Stryker

    Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more than 150 million patients annually. More information is available at www.stryker.com.

    Media Contact

    [email protected]



    Primary Logo

    Get the next $SYK alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SYK

    DatePrice TargetRatingAnalyst
    9/18/2025$420.00Neutral
    Rothschild & Co Redburn
    2/26/2025$450.00Buy
    Citigroup
    12/2/2024$370.00 → $445.00Equal-Weight → Overweight
    Morgan Stanley
    9/10/2024$405.00Outperform
    Wolfe Research
    5/30/2024$372.00Neutral
    Goldman
    5/22/2024$392.00Hold → Buy
    Needham
    1/31/2024$315.00 → $360.00Hold → Buy
    Canaccord Genuity
    10/20/2023$345.00Buy
    ROTH MKM
    More analyst ratings

    $SYK
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Stryker declares an $0.88 per share quarterly dividend

    Portage, Michigan, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable January 30, 2026, to shareholders of record at the close of business on December 31, 2025, representing an increase of 4.8% versus the prior year and previous quarter.  "We remain confident in our ability to deliver strong financial performance, and consistent with our capital allocation priorities we are increasing our dividend to $0.88 per share," said Kevin Lobo, Chair and Chief Executive Officer, Stryker. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are drive

    12/11/25 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker names Spencer Stiles President and Chief Operating Officer

    Portage, Michighan, Dec. 04, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK), a global leader in medical technologies, announced today Spencer Stiles has been appointed President and Chief Operating Officer (COO), effective January 1, 2026. In this role, Stiles will lead the company's global businesses, strategy, and mergers and acquisitions. "Appointing Spencer President and COO strengthens our ability to sustain high growth and leverage the breadth of our portfolio," said Kevin Lobo, Chair and CEO, Stryker. "Spencer's deep knowledge of our business and our customers, combined with his leadership and operational execution will help position us well for the future." Stiles, a twenty-seven-ye

    12/4/25 8:30:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker reports third quarter 2025 operating results

    Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2025: Third Quarter Results Reported net sales increased 10.3% to $6.1 billionOrganic net sales increased 9.5%Reported operating income margin of 18.7%Adjusted operating income margin(1) increased 90 bps to 25.6%Reported EPS increased 2.8% to $2.22Adjusted EPS(1) increased 11.1% to $3.19  Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        14.4        %         0.5        %         13.9        %         5.5        %         8.4        %Orthopaedics        3

    10/30/25 4:05:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    $SYK
    SEC Filings

    View All

    Group President Pierce James Andrew gifted 211 shares and received a gift of 211 shares, decreasing direct ownership by 0.32% to 65,630 units (SEC Form 4)

    4 - STRYKER CORP (0000310764) (Issuer)

    11/24/25 4:21:01 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    VP, Chief Financial Officer Wells Preston Wendell sold $60,370 worth of shares (165 units at $365.88), decreasing direct ownership by 2% to 6,694 units (SEC Form 4)

    4 - STRYKER CORP (0000310764) (Issuer)

    11/20/25 4:22:06 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    VP, Chief Accounting Officer Berry William E Jr exercised 4,925 shares at a strike of $154.14, covered exercise/tax liability with 2,972 shares and sold $713,802 worth of shares (1,953 units at $365.49) (SEC Form 4)

    4 - STRYKER CORP (0000310764) (Issuer)

    11/17/25 4:21:07 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure

    8-K - STRYKER CORP (0000310764) (Filer)

    12/4/25 4:16:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form 144 filed by Stryker Corporation

    144 - STRYKER CORP (0000310764) (Subject)

    11/14/25 4:27:05 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form 10-Q filed by Stryker Corporation

    10-Q - STRYKER CORP (0000310764) (Filer)

    10/31/25 10:39:02 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Rothschild & Co Redburn initiated coverage on Stryker with a new price target

    Rothschild & Co Redburn initiated coverage of Stryker with a rating of Neutral and set a new price target of $420.00

    9/18/25 8:44:39 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Citigroup resumed coverage on Stryker with a new price target

    Citigroup resumed coverage of Stryker with a rating of Buy and set a new price target of $450.00

    2/26/25 7:17:53 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Stryker from Equal-Weight to Overweight and set a new price target of $445.00 from $370.00 previously

    12/2/24 7:02:55 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Leadership Updates

    Live Leadership Updates

    View All

    Stryker showcases next generation of Mako SmartRobotics™ at AAOS 2025 Annual Meeting

    Latest technology offers more applications and innovation across more specialties MAHWAH, N.J., March 11, 2025 /PRNewswire/ -- Stryker (NYSE:SYK), a global leader in medical technologies, showcases the latest advancements in Mako SmartRobotics™ across hip, knee, spine and shoulder procedures at the American Academy of Orthopaedic Surgeons' (AAOS) 2025 Annual Meeting in San Diego. With over 1.5 million Mako procedures performed globally across 45 countries, Mako is a market-leading technology in orthopaedics. With the introduction of Mako Total Hip with Advanced Primary and Rev

    3/11/25 8:03:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Kadant Set to Join S&P SmallCap 600

    NEW YORK, Feb. 13, 2025 /PRNewswire/ -- Kadant Inc. (NYSE:KAI) will replace Inari Medical Inc. (NASD: NARI) in the S&P SmallCap 600 effective prior to the opening of trading on Wednesday, February 19. S&P 500 constituent Stryker Corp. (NYSE:SYK) is acquiring Inari Medical in a deal expected to be completed soon, pending final closing conditions. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name      Action Company Name Ticker GICS Sector February 19, 2025 S&P SmallCap 600 Addition Kadant KAI Industrials February 19, 2025 S&P SmallCap 600 Deletion Inari Medical NARI Health Care For more information about

    2/13/25 5:54:00 PM ET
    $KAI
    $NARI
    $SPGI
    Industrial Machinery/Components
    Industrials
    Medical/Dental Instruments
    Health Care

    Stryker announces the retirement of Glenn S. Boehnlein and the promotion of Preston Wells to Vice President, Chief Financial Officer

    Portage, Michigan, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today that Glenn S. Boehnlein will retire from his role as Vice President, Chief Financial Officer. Boehnlein's decision follows an impressive 22-year career at Stryker. Preston Wells, who currently serves as Group CFO for Stryker's Orthopaedics Group, will assume the role of Vice President, Chief Financial Officer effective April 1, 2025. "I want to thank Glenn for his performance drive, strong business partnership, and excellent leadership of the Finance and IT organizations. Glenn is a growth champion who invested in developing talent, including Preston Wells, who has been promoted to Chief Financial Offi

    1/28/25 4:05:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Financials

    Live finance-specific insights

    View All

    Stryker declares an $0.88 per share quarterly dividend

    Portage, Michigan, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable January 30, 2026, to shareholders of record at the close of business on December 31, 2025, representing an increase of 4.8% versus the prior year and previous quarter.  "We remain confident in our ability to deliver strong financial performance, and consistent with our capital allocation priorities we are increasing our dividend to $0.88 per share," said Kevin Lobo, Chair and Chief Executive Officer, Stryker. About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are drive

    12/11/25 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker reports third quarter 2025 operating results

    Portage, Michigan, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) reported operating results for the third quarter of 2025: Third Quarter Results Reported net sales increased 10.3% to $6.1 billionOrganic net sales increased 9.5%Reported operating income margin of 18.7%Adjusted operating income margin(1) increased 90 bps to 25.6%Reported EPS increased 2.8% to $2.22Adjusted EPS(1) increased 11.1% to $3.19  Third Quarter Net Sales Growth Overview Reported Foreign Currency Exchange Constant Currency Acquisitions / Divestitures OrganicMedSurg and Neurotechnology        14.4        %         0.5        %         13.9        %         5.5        %         8.4        %Orthopaedics        3

    10/30/25 4:05:00 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    Stryker declares an $0.84 per share quarterly dividend

    Portage, Michigan, Aug. 07, 2025 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.84 per share payable October 31, 2025, to shareholders of record at the close of business on September 30, 2025, representing an increase of 5.0% versus the prior year and unchanged from the previous quarter.  About Stryker Stryker is a global leader in medical technologies and, together with our customers, we are driven to make healthcare better. We offer innovative products and services in MedSurg, Neurotechnology and Orthopaedics that help improve patient and healthcare outcomes. Alongside our customers around the world, we impact more

    8/7/25 8:00:00 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    $SYK
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/12/24 10:18:54 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/14/23 12:37:55 PM ET
    $SYK
    Medical/Dental Instruments
    Health Care

    SEC Form SC 13G/A filed by Stryker Corporation (Amendment)

    SC 13G/A - STRYKER CORP (0000310764) (Subject)

    2/10/23 9:18:16 AM ET
    $SYK
    Medical/Dental Instruments
    Health Care